Skip to main content Back to Top
Advertisement

4/23/2021

Venlafaxine Hydrochloride Extended-Release Capsules

Products Affected - Description

    • Venlafaxine hydrochloride oral extended release capsule, Zydus, 150 mg, bottle, 30 count, NDC 68382-0036-06 - discontinued
    • Venlafaxine hydrochloride oral extended release capsule, Zydus, 37.5 mg, bottle, 30 count, NDC 68382-0034-06 - discontinued
    • Venlafaxine hydrochloride oral extended release capsule, Zydus, 75 mg, bottle, 30 count, NDC 68382-0035-06 - discontinued

Reason for the Shortage

    • Pfizer has Effexor XR capsules available.
    • Teva states the shortage was due to an active pharmaceutical ingredient shortage.
    • Zydus has venlafaxine extended-release capsules available. Zydus has discontinued the 30 count presentations.

Available Products

    • Effexor XR oral extended release capsule, Pfizer, 150 mg, bottle, 15 count, NDC 00008-0836-20
    • Effexor XR oral extended release capsule, Pfizer, 150 mg, bottle, 30 count, NDC 00008-0836-21
    • Effexor XR oral extended release capsule, Pfizer, 150 mg, bottle, 90 count, NDC 00008-0836-22
    • Effexor XR oral extended release capsule, Pfizer, 150 mg, unit-dose blister pack, 100 count, NDC 00008-0836-03
    • Effexor XR oral extended release capsule, Pfizer, 37.5 mg, bottle, 15 count, NDC 00008-0837-20
    • Effexor XR oral extended release capsule, Pfizer, 37.5 mg, bottle, 30 count, NDC 00008-0837-21
    • Effexor XR oral extended release capsule, Pfizer, 37.5 mg, bottle, 90 count, NDC 00008-0837-22
    • Effexor XR oral extended release capsule, Pfizer, 37.5 mg, unit-dose blister pack, 100 count, NDC 00008-0837-03
    • Effexor XR oral extended release capsule, Pfizer, 75 mg, bottle, 15 count, NDC 00008-0833-20
    • Effexor XR oral extended release capsule, Pfizer, 75 mg, bottle, 30 count, NDC 00008-0833-21
    • Effexor XR oral extended release capsule, Pfizer, 75 mg, bottle, 90 count, NDC 00008-0833-22
    • Effexor XR oral extended release capsule, Pfizer, 75 mg, unit-dose blister pack, 100 count, NDC 00008-0833-03
    • Venlafaxine hydrochloride oral extended release capsule, Teva, 150 mg, bottle, 30 count, NDC 00093-7386-56
    • Venlafaxine hydrochloride oral extended release capsule, Teva, 150 mg, bottle, 90 count, NDC 00093-7386-98
    • Venlafaxine hydrochloride oral extended release capsule, Teva, 150 mg, bottle, 500 count, NDC 00093-7386-05
    • Venlafaxine hydrochloride oral extended release capsule, Teva, 37.5 mg, bottle, 30 count, NDC 00093-7384-56
    • Venlafaxine hydrochloride oral extended release capsule, Teva, 37.5 mg, bottle, 90 count, NDC 00093-7384-98
    • Venlafaxine hydrochloride oral extended release capsule, Teva, 37.5 mg, bottle, 500 count, NDC 00093-7384-05
    • Venlafaxine hydrochloride oral extended release capsule, Teva, 75 mg, bottle, 30 count, NDC 00093-7385-56
    • Venlafaxine hydrochloride oral extended release capsule, Teva, 75 mg, bottle, 90 count, NDC 00093-7385-98
    • Venlafaxine hydrochloride oral extended release capsule, Teva, 75 mg, bottle, 500 count, NDC 00093-7385-05
    • Venlafaxine hydrochloride oral extended release capsule, Zydus, 150 mg, bottle, 90 count, NDC 68382-0036-16
    • Venlafaxine hydrochloride oral extended release capsule, Zydus, 150 mg, bottle, 1000 count, NDC 68382-0036-10
    • Venlafaxine hydrochloride oral extended release capsule, Zydus, 37.5 mg, bottle, 90 count, NDC 68382-0034-16
    • Venlafaxine hydrochloride oral extended release capsule, Zydus, 37.5 mg, bottle, 1000 count, NDC 68382-0034-10
    • Venlafaxine hydrochloride oral extended release capsule, Zydus, 75 mg, bottle, 90 count, NDC 68382-0035-16
    • Venlafaxine hydrochloride oral extended release capsule, Zydus, 75 mg, bottle, 1000 count, NDC 68382-0035-10

Updated

Updated April 23, 2021 by Leslie Jensen, PharmD, Drug Information Specialist. Created August 30, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT